Evidence map›Paper›PMID 27625096›Full record

ArticleChinese medical journal2016

Sulfur Dioxide Inhibits Extracellular Signal-regulated Kinase Signaling to Attenuate Vascular Smooth Muscle Cell Proliferation in Angiotensin II-induced Hypertensive Mice.

Hui-Juan Wu, Ya-Qian Huang, Qing-Hua Chen, Xiao-Yu Tian, Jia Liu, Chao-Shu Tang, Hong-Fang Jin, Jun-Bao Du

Open access · goldAbstract read
In one paragraph

Article in Chinese medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Effect of sulfur dioxide on vascular biology.Histology and histopathology · 2021
    Review
  4. Endothelial Cell-Derived SOOxidative medicine and cellular longevity · 2021
    Article
  5. Sulfur Dioxide Activates ClFrontiers in pharmacology · 2019
    Article
  6. Article
  7. Article
  8. Sulfur dioxide improves endothelial dysfunction by downregulating the angiotensin II/ATJournal of the renin-angiotensin-aldosterone system : JRAAS
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hui-Juan WuDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Ya-Qian HuangDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Qing-Hua ChenDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Xiao-Yu TianDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Jia LiuDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Chao-Shu TangDepartment of Physiology and Pathophysiology, Peking University Health Science Centre; Key Laboratory of Molecular Cardiology, Ministry of Education, Beijing 100091, China.
Hong-Fang JinDepartment of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Jun-Bao DuDepartment of Pediatrics, Peking University First Hospital, Beijing 100034; Key Laboratory of Molecular Cardiology, Ministry of Education, Beijing 100091, China.
Peking University First Hospital · CNPeking University · CNMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClarifying the mechanisms underlying vascular smooth muscle cell (VSMC) proliferation is important for the prevention and treatment of vascular remodeling and the reverse of hyperplastic lesions. Previous research has shown that the gaseous signaling molecule sulfur dioxide (SO2) inhibits VSMC proliferation, but the mechanism for the inhibition of the angiotensin II (AngII)-induced VSMC proliferation by SO2has not been fully elucidated. This study was designed to investigate if SO2inhibited VSMC proliferation in mice with hypertension induced by AngII.

methodsThirty-six male C57 mice were randomly divided into control, AngII, and AngII + SO2groups. Mice in AngII group and AngII + SO2group received a capsule-type AngII pump implanted under the skin of the back at a slow-release dose of 1000 ng·kg-1·min-1. In addition, mice in AngII + SO2received intraperitoneal injections of SO2donor. Arterial blood pressure of tail artery was determined. The thickness of the aorta was measured by elastic fiber staining, and proliferating cell nuclear antigen (PCNA) and phosphorylated-extracellular signal-regulated kinase (P-ERK) were detected in aortic tissues. The concentration of SO2 in serum and aortic tissue homogenate supernatant was measured using high-performance liquid chromatography with fluorescence determination. In the in vitro study, VSMC of A7R5 cell lines was divided into six groups: control, AngII, AngII + SO2, PD98059 (an inhibitor of ERK phosphorylation), AngII + PD98059, and AngII + SO2 + PD98059. Expression of PCNA, ERK, and P-ERK was determined by Western blotting.

resultsIn animal experiment, compared with the control group, AngII markedly increased blood pressure (P < 0.01) and thickened the aortic wall in mice (P < 0.05) with an increase in the expression of PCNA (P < 0.05). SO2, however, reduced the systemic hypertension and the wall thickness induced by AngII (P < 0.05). It inhibited the increased expression of PCNA and P-ERK induced by AngII (P < 0.05). In cell experiment, PD98059, an ERK phosphorylation inhibitor, blocked the inhibitory effect of SO2on VSMC proliferation (P < 0.05).

conclusionsERK signaling is involved in the mechanisms by which SO2inhibits VSMC proliferation in AngII-induced hypertensive mice via ERK signaling.

Indexed as

Angiotensin IIAnimalsCell ProliferationExtracellular Signal-Regulated MAP KinasesHypertensionMaleMiceMuscle, Smooth, VascularSignal TransductionSulfur DioxideAngiotensin IIExtracellular Signal-Regulated MAP KinasesSulfur Dioxide

Identifiers

PMID27625096
PMCPMC5022345
OpenAlexW2511231087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.